
14
|
Miton UK MicroCap Trust plc
|
Annual Report 2023
example underlines why a microcap portfolio can
deliver such strong returns over the longer term.
The Trust’s individual holdings have the potential
to appreciate by a multiple of their initial purchase
price. There were a few examples this year, but in a
normal year these would be more numerous.
In the light of the substantial decline in the Trust’s
NAV over the last two years, to what degree have its
longer-term prospects deteriorated?
After the global pandemic, and the giant financial
stimulus, global assets valuations rose to very
elevated levels in early 2021. Subsequently, over the
two years to April 2023, global asset valuations have
retreated somewhat, back towards prior norms, due
to inflationary pressures and interest rate rises.
Interestingly, although the UK stock market
underperformed most international exchanges
during the globalisation decades, over the last
two years it has now started outperforming all
the international major indices. Specifically, the
recent outperformance is all the more impressive
given that UK open ended investment companies
(“OEICs”) have been redeemed at a near-record pace
for several quarters. In our view, this underlines just
how undervalued the UK stock market had become
over the globalisation decades when assets paying
good and growing dividends were outpaced by
those with ambitious growth targets.
During the globalisation decades, UK-quoted
microcaps were also overlooked. Whilst they did
outperform during the year to April 2021, as few
pay significant dividends, their share prices have
been vulnerable to the global decline in asset
valuations and the ongoing selling of UK equities
over the last two years. The share prices of quoted
microcaps have underperformed those of the UK
majors by a very wide margin. Since many were
undervalued relative to the UK majors even prior
this underperformance, microcaps are in many
cases now standing on low valuations in our view.
Clearly, the rise in interest rates and the economic
slowdown will have reduced the longer-term
prospects for some. But when their prospects
are considered in absolute terms, it should be
remembered that corporate sales tend to rise with
inflation. In addition, those with strong balance
sheets stand at an advantage compared to those
which are capital constrained. Furthermore, if there
is a major rise in corporate insolvencies, then those
that are well financed can expand into the vacated
markets, or acquire the overindebted but otherwise
viable businesses, debt-free from the receiver at
very low prices.
The bottom line is that despite the current
economic slowdown and weak microcap share
prices, we believe the prospects for most of the
Trust’s holdings are actively improving. Their
relatively unleveraged balance sheets, and ongoing
access to external risk capital (albeit at weak share
prices) become all the more valuable when most
private competitors are facing increasingly binding
debt and capital constraints.
What are the main factors that have driven the
Trust’s returns since it first listed in April 2015?
As noted earlier in the report, the best performing
group of stocks in the UK stock market since 1955
(the start of the data series) have been quoted
microcaps. When the investment universe is
narrowed further, to include solely microcaps
standing on undemanding valuations (this is
typically determined by a low Price/Book ratio),
the scale of microcap outperformance is even
more marked. With this background in mind, the
Trust’s portfolio is principally invested in UK quoted
microcaps standing on what we consider to be
cheap valuations at the time of purchase. When
these microcaps succeed, their share prices can rise
by a multiple of the purchase price whereas this is
less usual amongst the mainstream stocks.
Investment Manager’s Report continued